Bioasis Technologies Inc (BIOAF)
0.004
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Bioasis Technologies Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| November 30, 2022 | -0.8207 |
| August 31, 2022 | -1.178 |
| May 31, 2022 | -0.8267 |
| February 28, 2022 | -0.9919 |
| November 30, 2021 | -1.296 |
| August 31, 2021 | -5.803 |
| May 31, 2021 | -2.127 |
| February 28, 2021 | 0.2788 |
| November 30, 2020 | 0.3104 |
| August 31, 2020 | -0.2077 |
| May 31, 2020 | -0.1956 |
| February 29, 2020 | -0.4036 |
| November 30, 2019 | -0.29 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-5.803
Minimum
Aug 2021
0.3104
Maximum
Nov 2020
-0.9034
Average
-0.4036
Median
Feb 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.298M |
| Total Liabilities (Quarterly) | 3.283M |
| Shareholders Equity (Quarterly) | -1.985M |